Alterations in BECN1 and some ATG genes, such as ATG5 and ATG4, which limit the efficacy of autophagic processes, have also been observed in liver, breast, prostate and ovarian tumors, confirming that autophagy plays a tumor-suppressive role in different tissue contexts [47,48,49]. This evidence concerns the gene BECN1 and neoplasm.